All resources

Does Cialis Stop Working? What Long-Term Tadalafil Studies Show About Tolerance

Does Cialis stop working over time? A 2024 two-year tadalafil study and a 2006 six-month analysis show group durability—not that every man is immune to change.

Educational content · Not medical advice · Provider evaluation required for any treatment

In this guide · 9 sections

Forum threads treat “Cialis stopped working” as proof that everyone builds tolerance — or as proof that anyone who loses response must have been dosing wrong.

Neither slogan matches the long-term evidence. In a 2024 multicenter open-label study, erectile-function gains on tadalafil held through two years at the group level. An older six-month post hoc analysis of a randomized, placebo-controlled trial also found maintained benefit. That is group durability, not a guarantee that your personal response never changes — and not proof that “worn-out receptors” is the default explanation when it does.

This is a Research / Evidence Update for men (including athletes and men on hormone care) who are searching does Cialis stop working or tadalafil tolerance. It is education for a licensed-provider conversation — not a diagnosis, not a dosing or titration protocol, and not advice to start, stop, or change any prescription.

If you are choosing daily vs as-needed schedules, use Should you take tadalafil daily or as needed?. If the question is which PDE5 drug, use tadalafil vs sildenafil. If ED feels multifactorial, use why ED is not just blood flow. This page owns the tolerance / long-term durability evidence question.

What Changed — and Why This Question Keeps Coming Up

Two pressures keep the tolerance myth alive:

  1. Individual change is real and memorable. A pill that used to feel reliable and now feels inconsistent is an observation worth clinical attention. “My receptors are worn out” is only one theory among many.
  2. Long-term group data is quieter than forum anecdotes. Open-label durability studies do not go viral the way a single “it stopped working” screenshot does.

Athletes and performance-minded men often meet this question after months or years of labeled use, during a hormone-protocol change, or after lifestyle shifts that also affect erectile function. The useful research question is whether controlled and long-term evidence shows inevitable fade — not whether every Reddit thread ends with dose-escalation lore.

Previous Understanding

Three slogans dominate:

  • “Everyone builds tolerance.” Treats any late change as receptor burnout.
  • “It can never stop helping.” Treats group means as a personal warranty.
  • “If it faded, you need a stronger prescription.” Skips the differential: vascular health, sleep, meds, hormones, relationship context, adherence, alcohol, and other contributors covered in the multifactorial ED guide.

All three oversimplify. PDE5 inhibitors remain prescription medicines with labeled contraindications (including nitrates) and serious adverse-event warnings that belong with a prescriber or urgent care — not a forum workaround.

New Evidence

2024: two-year open-label durability (Asian Journal of Andrology)

A multicenter, randomized, open-label, post-marketing study enrolled 635 Chinese men with ED. Erectile-function improvement held through two years: the IIEF-EF least-squares mean change was 7.9 at month 12 and 8.6 at month 24 (PubMed 38284776).

Limits that matter for the tolerance slogan:

  • It was open-label — participants knew what they were getting.
  • The long-term phase had no placebo comparison.
  • Only 475 of 635 (74.8%) completed 24 months.

A long-term result partly describes the people who stayed. It cannot show that every starter had the same experience, or that every dropout left because treatment failed. It also cannot prove that no individual ever lost response.

Athlete reading: group-level benefit can remain solid while one person’s response still changes. Those statements are not contradictions.

2006: six-month tolerance question in a placebo-controlled context

A post hoc analysis of an older randomized, placebo-controlled trial (93 men on as-needed tadalafil, 47 on placebo) found the benefit was maintained over six months. Describe it as a post hoc analysis, not a new standalone trial — but it is a direct look at whether the effect faded across that window in a controlled setting (PubMed 16681476).

Claim onlineWhat these studies supportWhat they do not prove
“Cialis always stops working”Not supported as a group-level law in these long-term datasetsThat no individual ever loses response
“Tolerance is inevitable”Not the default reading of 6–24 month durability evidenceThat receptor theory is never worth a clinician’s time
“If it changed, receptors are fried”Change is a real observationThat “tolerance” is the only or primary explanation
“Group durability = personal lock”Means can stay elevated for completersThat every starter matches the completer mean

What the Evidence Does Not Establish

This stack does not prove:

  • That tadalafil never loses effectiveness for any man
  • That open-label completer data equals a placebo-controlled two-year warranty
  • That dropouts had the same trajectory as completers
  • That a changed response means you should escalate without clinical review
  • That schedule choice (daily vs as-needed) is settled by tolerance lore alone — see the daily vs as-needed guide
  • That Anabolic Insights can diagnose why your response changed

Proprietary platform rates of “stopped working” reports are unavailable for this article — do not invent them.

Athlete and Hormone-Care Relevance

Hard-training men often collapse several timelines into one story: a new training block, worse sleep, a cut, alcohol changes, a TRT adjustment, and a PDE5 tablet that “used to work.” Tolerance is only one possible line on that list.

Useful clinical conversation prompts (not a self-workup):

  • What else changed in the same months — sleep, stress, alcohol, new meds, body weight, relationship context?
  • Is the complaint desire, erection reliability, orgasm, or anxiety after prior failures?
  • Are labeled safety constraints still clear (nitrates; seek urgent care for prolonged erection or sudden vision/hearing loss per label language)?

If a licensed provider determines tadalafil (Cialis) is appropriate, product context lives on the storefront Cialis / tadalafil page. Soft product context only — not a protocol.

Practical Implications

  1. Treat “worked before, works differently now” as an observation — bring it to a clinician instead of crowning a receptor theory online.
  2. Do not read group durability as a personal promise — or as proof that fade never happens.
  3. Prefer “what changed?” over “what stronger dose do I need?” — especially when hormones, sleep, and vascular risk factors are also moving.
  4. Keep schedule and molecule questions on their own pages — daily vs as-needed and tadalafil vs sildenafil are different intents.
  5. Safety stays label-framed — nitrate interactions and serious adverse events are prescriber / urgent-care territory, not DIY workarounds.

Questions Still Unanswered

Honest gaps remain:

  • Placebo-controlled durability past the windows these analyses cover
  • How often individual loss of response is true pharmacologic tolerance versus competing causes
  • How hormone-protocol changes interact with perceived PDE5 response in routine care (not settled by these two papers)

Unanswered is not “tolerance is proven.” Unanswered means do not oversell either extreme.

Bottom Line

Long-term tadalafil evidence does not support “everyone builds tolerance so Cialis stops working.” A 2024 two-year open-label study showed sustained IIEF-EF gains at the group level, and a 2006 post hoc analysis of a placebo-controlled trial found maintained benefit over six months. Completer bias, open-label design, and missing placebo in the long-term phase all limit how far you can stretch those means. A changed personal response is still worth a licensed-provider visit — with “what else changed?” ahead of “my receptors are done.”

FAQs

Does Cialis stop working over time?

Not as a universal rule in the long-term datasets above. Group erectile-function improvements held through two years in the 2024 open-label study (PubMed 38284776) and through six months in the 2006 post hoc analysis (PubMed 16681476). Individual change can still happen for many reasons.

Is tadalafil tolerance real?

True pharmacologic tolerance is one proposed explanation when response changes. These studies do not make it the default diagnosis. Discuss the timeline and other contributors with a clinician.

Why did it work before and feel different now?

Possible contributors include adherence, alcohol, sleep, stress, new medications, vascular or metabolic changes, and hormone context — not only receptor fatigue. See why ED is not just blood flow.

Should I switch to daily tadalafil if as-needed feels weaker?

Schedule choice is a clinical fit question, not a tolerance protocol. Use the daily vs as-needed decision guide as education before a provider visit — not as a DIY switch plan.

Discussion: we posted a short version of this on Reddit, join the thread.

For educational purposes; not a substitute for medical advice, diagnosis, or treatment. Always consult a licensed medical provider about your health, laboratory results, or medications. Medication eligibility and prescriptions are determined solely by licensed medical providers after evaluation; a prescription is not guaranteed. If you are experiencing a medical emergency, call 911.

Keep reading.

Prescriptions

Daily vs As-Needed Tadalafil: How Big Was the Difference in Trials?

Daily tadalafil beat on-demand by ~1.24 IIEF-EF points in a 2019 meta of 4 RCTs—the CI runs from barely any difference to a moderate one.

Read the article
Prescriptions

Why Do Men Prefer Cialis Over Viagra? What Patient-Preference Studies Show

Why prefer Cialis over Viagra if trials look similar? Preference studies and online reviews answer different questions—not “which is stronger.”

Read the article
Verify Approval for www.anabolicinsights.ai

A health-technology platform that connects members to licensed providers, labs, and pharmacies.

© 2026 Anabolic Insights. All rights reserved.

Anabolic Insights is operated by Sozo Diagnostics, Inc. · LinkedIn · Crunchbase

For educational purposes; not a substitute for medical advice, diagnosis, or treatment.